EE00773U1 - Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks - Google Patents

Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks

Info

Publication number
EE00773U1
EE00773U1 EEU200800003U EEU200800003U EE00773U1 EE 00773 U1 EE00773 U1 EE 00773U1 EE U200800003 U EEU200800003 U EE U200800003U EE U200800003 U EEU200800003 U EE U200800003U EE 00773 U1 EE00773 U1 EE 00773U1
Authority
EE
Estonia
Prior art keywords
salt
production
escitalopram base
free escitalopram
free
Prior art date
Application number
EEU200800003U
Other languages
English (en)
Estonian (et)
Inventor
Dancer Robert
Petersen Hans
Nielsen Ole
Harold Rock Michael
Eliasen Helle
Liljegren Ken
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE00773(U1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of EE00773U1 publication Critical patent/EE00773U1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
EEU200800003U 2005-06-22 2006-06-22 Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks EE00773U1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500912 2005-06-22
PCT/DK2006/000366 WO2006136169A2 (en) 2005-06-22 2006-06-22 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Publications (1)

Publication Number Publication Date
EE00773U1 true EE00773U1 (et) 2008-10-15

Family

ID=37546630

Family Applications (1)

Application Number Title Priority Date Filing Date
EEU200800003U EE00773U1 (et) 2005-06-22 2006-06-22 Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks

Country Status (39)

Country Link
EP (3) EP1896439B2 (is)
JP (5) JP4906852B2 (is)
KR (5) KR20110084341A (is)
CN (2) CN101928269A (is)
AR (2) AR055062A1 (is)
AT (3) AT10983U1 (is)
AU (2) AU2006261452B2 (is)
BG (1) BG66086B1 (is)
BR (1) BRPI0612295A2 (is)
CA (2) CA2612827C (is)
CY (1) CY1112392T1 (is)
CZ (3) CZ300686B6 (is)
DE (2) DE112006001619T5 (is)
DK (3) DK1896439T4 (is)
EA (2) EA201001108A1 (is)
EE (1) EE00773U1 (is)
ES (2) ES2356838T5 (is)
FI (2) FI20077133A (is)
GB (2) GB2448834B (is)
HR (1) HRP20110093T4 (is)
HU (1) HUP0800135A3 (is)
IL (1) IL187454A0 (is)
IS (1) IS8705A (is)
LT (1) LT5550B (is)
LV (1) LV13677B (is)
MX (1) MX2007015328A (is)
MY (2) MY143239A (is)
NO (2) NO20080359L (is)
PL (2) PL1896439T5 (is)
PT (1) PT1896439E (is)
RS (1) RS51575B2 (is)
SG (1) SG169358A1 (is)
SI (1) SI1896439T2 (is)
SK (1) SK500402007A3 (is)
TR (2) TR200708792T1 (is)
TW (2) TWI347942B (is)
UA (1) UA86536C2 (is)
WO (1) WO2006136169A2 (is)
ZA (2) ZA200711066B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
EP2134325A2 (en) * 2007-03-01 2009-12-23 Aurobindo Pharma Limited Stable solid dosage forms of an antidepressant
ME02391B (me) 2010-07-23 2016-09-20 H Lundbeck As Postupak za prečišćavanje farmaceutski prihvatljivih soli escitaloprama
CN103360353A (zh) * 2013-08-07 2013-10-23 中国药科大学 草酸艾司西酞普兰杂质的制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) * 2017-04-10 2018-11-14 東和薬品株式会社 エスシタロプラム医薬組成物
CN110711198B (zh) * 2018-07-12 2022-03-15 山东大学 D-甘露糖在制备抗抑郁药物中的应用
KR102331187B1 (ko) 2019-04-09 2021-11-26 주식회사 라이트팜텍 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JPH05222041A (ja) * 1992-02-13 1993-08-31 Mitsubishi Gas Chem Co Inc アデニン誘導体の精製法
SG46962A1 (en) * 1994-01-27 1998-03-20 Janssen Pharmaceutica Inc Rapidly dissolving oral dosage form
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
DE69717317T2 (de) 1997-06-30 2003-10-02 Beloit Technologies, Inc. Verfahren und vorrichtung zum auftragen einer beschichtung auf eine bei hoher geschwindigkeit laufende papierbahn
PT1015416E (pt) 1997-07-08 2002-03-28 Lundbeck & Co As H Metodo para a producao de citalopram
JP3813820B2 (ja) 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
EP1334716A4 (en) * 2000-10-16 2009-04-29 Daiichi Seiyaku Co MEDICAL COMPOSITIONS THAT CAN RAPIDLY DISINTEGRATE IN ORAL CAVITY AND METHOD OF PRODUCING THE SAME
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
PT1181713E (pt) * 2000-12-22 2005-02-28 Lundbeck & Co As H Metodo para preparacao de citalopram puro
PT1181272E (pt) * 2000-12-28 2003-01-31 Lundbeck & Co As H Processo para a preparacao de citalopram puro
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
DK1522539T3 (da) * 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
US7148364B2 (en) * 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
WO2003092659A1 (en) * 2002-05-03 2003-11-13 Skyepharma Canada Inc. Oral dosage forms comprising fenofibrate
CA2511142A1 (en) 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
CN1510024A (zh) * 2002-12-24 2004-07-07 北京德众万全药物技术开发有限公司 可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
EP1620075B1 (en) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
ES2688193T3 (es) * 2003-10-15 2018-10-31 Fuji Chemical Industry Co., Ltd. Comprimido de disgregación rápida en la cavidad oral
WO2005049596A1 (en) * 2003-11-20 2005-06-02 Natco Pharma Limited A process for the preparation of high purity escitalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
CA2558198A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts

Also Published As

Publication number Publication date
TWI347942B (en) 2011-09-01
AR079750A2 (es) 2012-02-15
ZA200711066B (en) 2009-07-29
GB0811164D0 (en) 2008-07-23
AU2006261452B2 (en) 2010-02-04
JP5731957B2 (ja) 2015-06-10
JP2009179635A (ja) 2009-08-13
CA2612827C (en) 2010-11-30
ES2319073B1 (es) 2010-02-26
LT5550B (lt) 2009-03-25
WO2006136169A2 (en) 2006-12-28
CY1112392T1 (el) 2015-12-09
GB2442160A (en) 2008-03-26
NO20101777L (no) 2008-01-18
AU2006261452A1 (en) 2006-12-28
BG110024A (bg) 2008-05-30
RS51575B (en) 2011-08-31
SI1896439T1 (sl) 2011-03-31
HRP20110093T1 (hr) 2011-03-31
CA2612827A1 (en) 2006-12-28
TR201000625T1 (tr) 2010-03-22
GB2442160B (en) 2010-01-20
HRP20110093T4 (hr) 2015-02-27
HUP0800135A3 (en) 2009-01-28
EP2325177A1 (en) 2011-05-25
KR20100133023A (ko) 2010-12-20
MY143239A (en) 2011-04-15
AR055062A1 (es) 2007-08-01
KR20080018191A (ko) 2008-02-27
AT11883U1 (de) 2011-06-15
UA86536C2 (ru) 2009-04-27
CA2646780A1 (en) 2006-12-28
PL1896439T3 (pl) 2011-04-29
DK1896439T4 (en) 2015-01-12
JP2009046506A (ja) 2009-03-05
BG66086B1 (bg) 2011-03-31
JP4415056B2 (ja) 2010-02-17
JP4906852B2 (ja) 2012-03-28
MX2007015328A (es) 2008-02-15
IL187454A0 (en) 2008-02-09
GB2448834A (en) 2008-10-29
ES2356838T3 (es) 2011-04-13
AU2010200844A1 (en) 2010-04-01
EA200800102A1 (ru) 2008-04-28
EP1896439B2 (en) 2014-10-15
DE112006001619T5 (de) 2008-06-12
JP2008546724A (ja) 2008-12-25
NO20080359L (no) 2008-01-18
BRPI0612295A2 (pt) 2011-01-04
DE602006019961D1 (de) 2011-03-17
CZ2007898A3 (cs) 2008-01-23
KR101340815B1 (ko) 2013-12-11
SG169358A1 (en) 2011-03-30
CZ301286B6 (cs) 2009-12-30
ES2356838T5 (es) 2015-01-26
JP2009179634A (ja) 2009-08-13
ZA200901698B (en) 2010-04-28
PL1896439T5 (pl) 2016-01-29
EP1896439A2 (en) 2008-03-12
ES2319073A1 (es) 2009-05-01
DK200900284A (da) 2009-02-27
TWI358407B (en) 2012-02-21
KR20110084341A (ko) 2011-07-21
TR200708792T1 (tr) 2008-05-21
LV13677B (en) 2008-05-20
DK1896439T3 (da) 2011-02-28
ATE497500T1 (de) 2011-02-15
HUP0800135A2 (en) 2008-06-30
SK500402007A3 (sk) 2008-05-06
SI1896439T2 (sl) 2014-12-31
RS51575B2 (sr) 2018-02-28
LT2008005A (en) 2008-10-27
CZ300686B6 (cs) 2009-07-15
GB0724557D0 (en) 2008-01-23
KR20110033310A (ko) 2011-03-30
EP2385044A1 (en) 2011-11-09
FI20077133A (fi) 2007-12-20
CN101928269A (zh) 2010-12-29
EA201001108A1 (ru) 2011-02-28
CN101189220A (zh) 2008-05-28
DK200800075A (da) 2008-03-15
IS8705A (is) 2008-01-14
AT10983U1 (de) 2010-02-15
EP1896439B1 (en) 2011-02-02
PL384185A1 (pl) 2008-06-23
TW200740785A (en) 2007-11-01
WO2006136169A3 (en) 2007-10-18
TW201130808A (en) 2011-09-16
KR20120064140A (ko) 2012-06-18
CZ299906B6 (cs) 2008-12-29
PT1896439E (pt) 2011-02-15
GB2448834B (en) 2010-01-20
FI20080548A (fi) 2008-10-07
MY143252A (en) 2011-04-15
EA019239B1 (ru) 2014-02-28
JP2012072168A (ja) 2012-04-12

Similar Documents

Publication Publication Date Title
DK1795576T3 (da) Fremgangsmåde til fremstilling af carbonhydrider
EE00773U1 (et) Meetod vaba estsitalopraam-aluse v?i selle soola tootmiseks
ATE518856T1 (de) Herstellverfahren
DE602005022650D1 (de) Verbessertes Plattierungsverfahren
FI20065404A (fi) Prosessi perusöljyn valmistamiseksi
DE602006018127D1 (de) Acetylenderivate
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
DE602005006185D1 (de) Entwicklungsverfahren
DE602005015459D1 (de) Folienherstellungsverfahren
MA28635B1 (fr) Methode de production de derives de 1, 4-diphenylazetidinone
DE602006016683D1 (de) Tonerherstellungsverfahren
DE602006020716D1 (de) Kastenloses formverfahren
IS2674B (is) Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni
DE602006012689D1 (de) Überprüfungsverfahren
FR2895406B1 (fr) Procede pour la fabrication de 2,3-dimethylbut-1-ene
ITMO20050001A1 (it) Procedimento per la produzione di oggetti decorativi puzzle.
DE602006001668D1 (de) Fehlerüberprüfungsverfahren
ZA200710796B (en) Process for reducing the cloud point of a base oil
ITMO20050135A1 (it) Procedimento per la produzione di polistirolo espanso.
DK1937662T3 (da) Fremgangsmåde til fremstilling af duloxetin
FR2894958B1 (fr) Procede de preparation de difluoroethanol
FI20050577A (fi) Menetelmä adamantaanijohdannaisten valmistamiseksi
DE602006004709D1 (de) Beschichtungsverfahren
DE602006018034D1 (de) Enzymherstellungsverfahren
JP2008525507A5 (ja) 置換された４−アルコキシカルボニル−３−アミノチオフェン類の製造方法

Legal Events

Date Code Title Description
EXFP Utility model extended to 8 or 10 years after payment of fee

Expiry date: 20140622

MA1K Renunciation

Effective date: 20110412